NO-Donating NSAIDs, PPAR, and Cancer: Does PPAR Contribute to Colon Carcinogenesis?
Figure 2
Effect of NO-ASA on PPARδ and apoptosis in colon tissue of Min mice. Upper panel: the evolution of necrotic
areas in intestinal tumors treated with p-NO-ASA; sections are
stained by the TUNEL method. (I) Coalescence of TUNEL positive cells (arrow),
representing the earliest stage; (II) abundant apoptotic cells at the
margins of the developing area with contrast to their rarity in the surrounding
area; (III) and (IV) the necrotic area is increasing in size, but
TUNEL positive cells persist at its margins; TUNEL positive areas within the
necrotic areas (arrows) suggest their cellular origin. Lower panel: the relationship of PPARδ and apoptosis in NO-ASA
treated intestinal tumors. Successive sections of intestinal tumors were
stained for PPAR expression and apoptosis. The untreated tumor shows strong
PPARδ expression (A) and rare apoptotic cells (B). After treatment
with meta or para NO-ASA, tumors show decreased PPARδ expression
(C) and (E) and
increased apoptosis (D) and (F). Magnification is x400, adapted
from Ouyang et al. [7].